⌘K
Loading ticker…
Edesa Biotech, Inc. Common Shares · Healthcare · Pharmaceutical Products
As of 2026-06-26, Edesa Biotech, Inc. Common Shares (EDSA) has a 3-month relative strength percentile of 86 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 96. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 16.7%, relative volume 0.28×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 86, Market Stance is mixed at 47, A/D rating A
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
EDSA appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $450K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $450K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EDSA Jan avg: -9.35% median: -10.12% win: 25% σ: 18.98% n: 4 2022-04-12 → 2026-05-29 | EDSA Feb avg: 25.53% median: 9.37% win: 75% σ: 42.44% n: 4 2022-04-12 → 2026-05-29 | EDSA Mar avg: 25.92% median: 1.09% win: 50% σ: 77.05% n: 4 2022-04-12 → 2026-05-29 | EDSA Apr avg: 50.65% median: 6.00% win: 60% σ: 112.22% n: 5 2022-04-12 → 2026-05-29 | EDSA May avg: -20.97% median: -15.88% win: 0% σ: 23.03% n: 5 2022-04-12 → 2026-05-29 | EDSA Jun avg: -7.58% median: -6.02% win: 25% σ: 11.26% n: 4 2022-04-12 → 2026-05-29 (current) | EDSA Jul avg: 11.90% median: 11.32% win: 100% σ: 9.30% n: 4 2022-04-12 → 2026-05-29 | EDSA Aug avg: -1.06% median: 3.20% win: 75% σ: 9.37% n: 4 2022-04-12 → 2026-05-29 | EDSA Sep avg: -17.76% median: -13.25% win: 25% σ: 25.99% n: 4 2022-04-12 → 2026-05-29 | EDSA Oct avg: -16.49% median: -25.27% win: 25% σ: 18.89% n: 4 2022-04-12 → 2026-05-29 | EDSA Nov avg: -9.96% median: -8.19% win: 25% σ: 12.01% n: 4 2022-04-12 → 2026-05-29 | EDSA Dec avg: 30.63% median: 9.74% win: 50% σ: 75.41% n: 4 2022-04-12 → 2026-05-29 |